Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 14, 2011; 17(38): 4321-4333
Published online Oct 14, 2011. doi: 10.3748/wjg.v17.i38.4321
Published online Oct 14, 2011. doi: 10.3748/wjg.v17.i38.4321
Table 2 Methodological quality of included randomized clinical trials
First author, year[Ref.] | Generation of allocation sequence | Allocation concealment | Blinding | Methodologicalquality |
Han, 2010[22] | Unclear | Unclear | Unclear | Low |
Zhang, 2010[21] | Unclear | Unclear | Unclear | Low |
Han, 2009[23] | Unclear | Unclear | Unclear | Low |
Su, 2009[24] | Unclear | Unclear | Unclear | Low |
Xu, 2009[25] | Unclear | Adequate | Adequate | High |
Shi, 2009[26] | Adequate | Adequate | Adequate | High |
Yang, 2008[27] | Adequate | Unclear | Unclear | Low |
Guo, 2008[28] | Adequate | Unclear | Unclear | Low |
Xiang, 2007[29] | Adequate | Unclear | Unclear | Low |
Feng, 2007[30] | Not done | Not done | Not done | Low |
Li, 2006[31] | Not done | Not done | Not done | Low |
Li, 2006[32] | Not done | Not done | Not done | Low |
Han, 2005[33] | Not done | Not done | Not done | Low |
Shi, 2005[34] | Adequate | Unclear | Unclear | Low |
Li, 2003[35] | Adequate | Unclear | Unclear | Low |
- Citation: Han L, Zhang HW, Xie JX, Zhang Q, Wang HY, Cao GW. A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus. World J Gastroenterol 2011; 17(38): 4321-4333
- URL: https://www.wjgnet.com/1007-9327/full/v17/i38/4321.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i38.4321